Non-Invasive Prenatal Testing (NIPT) Market to grow from $11.39 Bn (2024) to $14.48 Bn (2034) at CAGR 9.8%. Keyplayers: Natera, Illumina, Myriad Genetics.
Non-Invasive Prenatal Testing (NIPT) Market is transforming the landscape of prenatal care, offering safer and more accurate ways to detect chromosomal abnormalities in early pregnancy. …